Stereotaxis CEO David Fischel says the MAGiC catheter was designed "to overcome the natural limitations of manual pull-wire ...

Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond ...

Six advanced cardiac procedures were carried out for the first time in Egypt’s Aswan governorate without open-heart surgery, ...

Stereotaxis has won FDA approval for the MAGiC Magnetic Interventional Ablation Catheter. The device is a robotically ...

Dr. Peter Weiss, one of the biggest boosters of robotic magnetic navigation, offers his perspective on the needs of EPs and ...

Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, ...

Observing that urinary catheterisation is one of the treatment options for those suffering from Urethral Stricture, the ...

For high-risk patients, the method could offer a safer alternative to open-heart surgery.

A 40-year-old woman who was once accustomed to frequent travel suddenly found herself struggling to breathe after just a few ...

William Blair upgraded Medtronic, citing new product launches, FDA approvals, improving valuation, and clearer growth drivers ...

CMS has approved electrophysiology ablation procedures for the ASC setting, marking a major advancement for outpatient cardiology and potentially accelerating the specialization of cardiac ASCs.